More on Cepheid (CPHD): Q2 comes in-line on a per share basis but comes up shy on revenue...
More on Cepheid (CPHD): Q2 comes in-line on a per share basis but comes up shy on revenue despite a 20% Y/Y jump in total sales. Looking forward into the second half however, the company says it's taking a more cautious view. For FY 2012, the company expects revenue in the range of $333M to $347M and an EPS of $0.38 to $0.42 per share. The Street is at $342M in revenue on earnings of $0.49 per share. Shares remain halted AH.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs